![[LSUS] Life-Sciences-USA.com - The Transatlantic Life Sciences Web Portal](/images/basics/lsus-life-sciences-usa-portal-logo.svg){kind=logo}
Advertisement
Products > All
Find below all kinds of products, technologies and services from companies in North America & Europe or related to them.Total search results: 9428 | Ordered by Date (descending)
1 2 3 ... 93 94 95 
  Product |
Product Group |
Organisation |
 Date |
|---|---|---|---|
| Leqembi® | Alzheimer drug | Eisai (Group) | 2024-08-22 |
| Paveway™ PLUS E. coli expression system | protein expression technology | Fujifilm (Group) | 2024-08-20 |
| Reliant Tabular AI workbench | artificial intelligence_o | Reliant AI (Group) | 2024-08-20 |
| Centogene Biodatabank | genomic database | Centogene (Group) | 2024-08-07 |
| Intelligent Architecture™ platform | industrial enzyme | Biomatter Designs (LT) | 2024-08-05 |
| RESTORE+™ RNA editing platform | genomic technology | AIRNA (Group) | 2024-07-31 |
| BrainOnly™ platform (Montara Therapeutics / UCSF) | drug delivery technology for crossing blood-brain-barrier (BBB drug delivery) | 2024-07-30 | |
| VoyageR drug discovery platform | AI-based drug discovery technology | Revir Therapeutics (US) | 2024-07-26 |
| Krisalix™ discovery platform (for micropeptide-based active ingredients) (Micropep) | biological crop protection product (biopesticide) | Micropep Technologies SAS | 2024-07-25 |
| QTORIN™ rapamycin | pharmaceutical_oo | Palvella Therapeutics (Group) | 2024-07-24 |
| QTORIN™ topical drug delivery platform | topical drug delivery technology | Palvella Therapeutics (Group) | 2024-07-24 |
| Targeted Myeloid Engager and Phagocytosis Platform (bispecific antibody-based technology) | antibody technology | Dren Bio Inc. | 2024-07-24 |
| AbReptor™ antibody platform for targeted protein degradation | drug development technology | Pinetree Therapeutics Inc. | 2024-07-23 |
| Melt Extrusion Deposition 3D printing pharmaceutical technology (MED® technology) | oral drug delivery technology | 2024-07-23 | |
| Huma Cloud Platform | digital health (healthcare informatics)_o | Huma Therapeutics (Group) | 2024-07-16 |
| Epygon mitral valve | valve (medical) | Affluent Medical (Group) | 2024-07-12 |
| AVITI24™ sequencing system | DNA sequencing system_other | Element Biosciences Inc. | 2024-07-11 |
| PINK! Coach | disease/treatment management software | Sidekick Health (Group) | 2024-06-18 |
| J.P. Morgan 270 Life Sciences Private Capital Fund I | fund, human health | JPMorgan Chase (Group) | 2024-06-13 |
| Foresite Capital Fund VI | fund, human health | Foresite Capital (Group) | 2024-06-12 |
| SYNT™ technology platform (SYNthetic Tissue-lining technology) | oral drug delivery technology | Syntis Bio Inc. | 2024-06-11 |
| Amber-UI implantable adaptive neuromodulation therapy | neuromodulation device | Amber Therapeutics Ltd. | 2024-06-10 |
| Iqirvo® | pharmaceutical_oo | Ipsen (Group) | 2024-06-10 |
| Picostim System | neuromodulation device | Amber Therapeutics Ltd. | 2024-06-10 |
| Brandon Capital Fund V | fund, human health | Brandon Capital (Group) | 2024-06-04 |
| Brandon Capital Fund VI | fund, human health | Brandon Capital (Group) | 2024-06-04 |
| Tarpeyo® (delayed release capsules) | glucocorticoid | Asahi Kasei (Group) | 2024-06-04 |
| OmciSoft Land Databases | biological/chemical database_o | Qiagen (Group) | 2024-06-03 |
| Genetic Syntax Engine (ExpressionEdits) | genomic technology | ExpressionEdits Ltd. | 2024-05-29 |
| Restoret™ | ophthalmic_o | Eyebiotech Ltd. (EyeBio) | 2024-05-29 |
| hTSC platform (human trophoblast stem cell platform) | stem cell technology | Accelerated Biosciences Corporation (US/TW) | 2024-05-16 |
| Opmed.ai AI-powered platform for optimization of operating room (OR) scheduling and resource allocation | AI-based healthcare/medical product | Opmed Inc. (Opmed.ai) | 2024-05-07 |
| Mekanofection™ platform | gene therapy technology | 2024-05-02 | |
| MiXCR software platform | genomic software tools | 2024-04-29 | |
| Beqvez™ | gene therapy hemophilia B | Pfizer (Group) | 2024-04-26 |
| Elecsys® pTau217 plasma biomarker test | clinical proteomic test | Roche (Group) | 2024-04-11 |
| Glyph™ technology platform | drug development technology | Seaport Therapeutics (US) | 2024-04-09 |
| Tmod™ cell therapy platform (Tmod™ technology) | cell therapy technology | A2 Biotherapeutics Inc. (A2 Bio) | 2024-03-25 |
| Mirador360™ precision development engine | drug development technology | Mirador Therapeutics Inc. | 2024-03-21 |
| Aurase® Wound Gel | wound care product_o | SolasCure Ltd. | 2024-03-20 |
| Jeraygo™/Tryvio™ | endothelin receptor antagonist | Idorsia (Group) | 2024-03-20 |
| eProtein Discovery™ benchtop system | drug discovery technology_o | Nuclera (Group) | 2024-03-14 |
| Cara Care digital therapeutic app for digestive diseases | digital health (healthcare informatics)_o | Mahana Therapeutics (Group) | 2024-03-12 |
| Deal biopharma partnering CRM | software, office | Inpart (Group) | 2024-02-29 |
| NULISA™ technology | proteomic technology | 2024-02-26 | |
| Nio™+ digital PCR instrument | thermocycler (thermal cycler)_o | Stilla Technologies (Group) | 2024-02-22 |
| Ignite™ virtual screening drug discovery technology | structure-based drug design | Cresset BioMolecular Discovery Ltd. | 2024-02-21 |
| rPEG lipids for nucleic acid delivery (randomized polyethylene glycols) | vector (biotech) | Evonik (Group) | 2024-02-20 |
| DDX platform (Dually Derivatized Oligochitosan platform) | gene therapy technology | EnGene (Group) | 2024-02-14 |
| EG-70 (genetic medicine, EnGene) | biopharmaceutical_o | EnGene (Group) | 2024-02-14 |
| AISight® Image Management System (IMS) | data management and workflow software (bioinformatics) | PathAI (Group) | 2024-02-13 |
| Casgevy™ | stem cell therapy | CRISPR Therapeutics (Group) | 2024-02-13 |
| Enable BIOS platform (Biological Insight, Operating and Search) | data integration and analysis software (bioinformatics) | Enable Medicine (US) | 2024-02-13 |
| Navify® Digital Pathology platform | pathology system | 2024-02-13 | |
| Zepbound | obesity drug_o | Eli Lilly (Group) | 2024-02-13 |
| Scion Life Sciences (Fund 1, final close 2/24) | fund, human health | Petrichor (Group) | 2024-02-07 |
| FLASHDEEP FLASH radiotherapy system | radiotherapy system | 2024-02-02 | |
| Exblifep® | antibiotic | Allecra Therapeutics (Group) | 2024-02-01 |
| Nadmed technology | diagnostics (medical/biological)_oo | Nadmed Oy | 2024-02-01 |
| 96 well PLA plate, Green Elephant Biotech | 96 well plate (96-well plate) | Green Elephant Biotech GmbH | 2024-01-29 |
| SciY platform | data integration and analysis software (bioinformatics) | Bruker (Group) | 2024-01-25 |
| Mirae Asset Capital Life Science Inception I, LP (fund) | fund, human health | Mirae Asset (Group) | 2024-01-18 |
| AlphaDirect™ Lead-212 (Pb-212) isolation technology | RADIOPHARMACEUTICAL (RPT) | 2024-01-08 | |
| aexLNP system | vector (biotech) | BioNTech (Group) | 2024-01-06 |
| Clear-X™ linker technology | RADIOPHARMACEUTICAL (RPT) | Full-Life Technologies (Group) | 2024-01-04 |
| Res-X™ modification methods | RADIOPHARMACEUTICAL (RPT) | Full-Life Technologies (Group) | 2024-01-04 |
| West Street Life Sciences I Fund (Goldman Sachs) | fund, human health | Goldman Sachs (Group) | 2024-01-03 |
| Anktiva® | cancer drug_o | ImmunityBio, Inc. (Nasdaq: IBRX) | 2024-01-02 |
| L-PGI technology (ligase-mediated programmable genomic integration technology) | genomic technology | Tome Biosciences (Group) | 2024-01-02 |
| ARGO™ HT System | proteomic technology | Alamar Biosciences Inc. | 2024-01-01 |
| NULISAseq™ Inflammation Panel 250 | proteomic technology | Alamar Biosciences Inc. | 2024-01-01 |
| MTIP Fund II | fund, human health_o | MTIP (Group) | 2023-12-31 |
| GrowInk-ALG bioink | bioink | UPM (FI) (Group) | 2023-12-21 |
| GrowInk-N bioink | bioink | UPM (FI) (Group) | 2023-12-21 |
| GrowInk-T bioink | bioink | UPM (FI) (Group) | 2023-12-21 |
| MSIntuit® CRC test | cancer test | Owkin (Group) | 2023-12-19 |
| PETRA III synchrotron lightsource (at DESY) | laboratory equipment and instruments_oo | Helmholtz-Gemeinschaft (HGF) (Group) | 2023-12-14 |
| I-PGI technology (integrase-mediated programmable genomic integration technology) | genomic technology | Tome Biosciences (Group) | 2023-12-12 |
| Katana iPS-T cell therapy paltform (CD8aß iPS-T cell platform) | T cell therapy | 2023-12-12 | |
| PASTE technology (Tome Biosciences / MIT) | genomic technology | Tome Biosciences (Group) | 2023-12-12 |
| programmable genomic integration technology (PGI technology) | genomic technology | Tome Biosciences (Group) | 2023-12-12 |
| Z-Screen™ platform | drug screening (HTS) | Zafrens (US) | 2023-12-11 |
| Aiddison™ drug discovery software | drug discovery software | MilliporeSigma (business unit of Merck KGaA) | 2023-12-05 |
| ConformalFLASH® technology | proton therapy | 2023-12-05 | |
| Synthia™ retrosynthesis software application programing interface (API) integration | drug discovery software | MilliporeSigma (business unit of Merck KGaA) | 2023-12-05 |
| Chemotype Evolution discovery platform | drug discovery technology_o | Roche (Group) | 2023-12-04 |
| Nvidia BioNemo | drug discovery software | Nvidia (Group) | 2023-11-21 |
| Nvidia DGX Cloud | cloud computing | Nvidia (Group) | 2023-11-21 |
| RlapsRisk® BC test | cancer test | Owkin (Group) | 2023-11-21 |
| Evinova drug development suite | clinical software tools | AstraZeneca (Group) | 2023-11-20 |
| polyNaut® drug delivery platform | drug delivery technology_o | ViaNautis Bio Ltd. | 2023-11-13 |
| vivoXPRESS® manufacturing platform | biopharmaceutical production technology (biomanufacturing) | PlantForm Corporation (CA) | 2023-11-13 |
| Akrivis GD™ early-stage liquid biopsy test for ovarian cancer | cancer test | AOA Dx (US) | 2023-11-12 |
| Ixchiq® | vaccine_o | Valneva (Group) | 2023-11-10 |
| EMERGE bio-analytics platform | AI-based drug discovery technology | Liquid Biosciences (US) | 2023-11-09 |
| CloneSelect® Imager FL | cell analysis technology | Danaher (Group) | 2023-11-07 |
| DispenCell™ single-cell dispenser | cell dispenser | Danaher (Group) | 2023-11-07 |
| Abingworth Clinical Co-Development Co-Investment Fund (CCD-CIF) | fund, human health | Carlyle (Group) | 2023-10-30 |
| Agamree® | pharmaceutical_oo | Santhera (Group) | 2023-10-27 |
| DXd antibody-drug conjugate technology | drug development technology | Daiichi Sankyo (Group) | 2023-10-19 |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
